DAC vs. OLMA
Compare and contrast key facts about Danaos Corporation (DAC) and Olema Pharmaceuticals, Inc. (OLMA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DAC or OLMA.
Performance
DAC vs. OLMA - Performance Comparison
Returns By Period
In the year-to-date period, DAC achieves a 17.61% return, which is significantly higher than OLMA's -40.98% return.
DAC
17.61%
-0.79%
-2.33%
26.49%
76.65%
1.62%
OLMA
-40.98%
-31.40%
-10.10%
-41.69%
N/A
N/A
Fundamentals
| DAC | OLMA | |
|---|---|---|
| Market Cap | $1.67B | $474.43M |
| EPS | $28.56 | -$2.28 |
| Total Revenue (TTM) | $996.31M | $1.88M |
| Gross Profit (TTM) | $654.48M | $1.61M |
| EBITDA (TTM) | $709.40M | -$135.54M |
Key characteristics
| DAC | OLMA | |
|---|---|---|
| Sharpe Ratio | 1.19 | -0.64 |
| Sortino Ratio | 1.77 | -0.73 |
| Omega Ratio | 1.22 | 0.91 |
| Calmar Ratio | 0.32 | -0.57 |
| Martin Ratio | 2.95 | -1.76 |
| Ulcer Index | 9.23% | 27.38% |
| Daily Std Dev | 22.97% | 75.23% |
| Max Drawdown | -99.42% | -96.26% |
| Current Drawdown | -79.66% | -84.81% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between DAC and OLMA is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
DAC vs. OLMA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Danaos Corporation (DAC) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DAC vs. OLMA - Dividend Comparison
DAC's dividend yield for the trailing twelve months is around 3.78%, while OLMA has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
DAC Danaos Corporation | 3.78% | 4.12% | 5.70% | 2.01% |
OLMA Olema Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
DAC vs. OLMA - Drawdown Comparison
The maximum DAC drawdown since its inception was -99.42%, roughly equal to the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for DAC and OLMA. For additional features, visit the drawdowns tool.
Volatility
DAC vs. OLMA - Volatility Comparison
The current volatility for Danaos Corporation (DAC) is 6.26%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 20.43%. This indicates that DAC experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DAC vs. OLMA - Financials Comparison
This section allows you to compare key financial metrics between Danaos Corporation and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities